Pharmaceutical Market Access and Drug Safety Act of 2009
Latest action · Mar 5, 2009 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 4, 2009
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pharmaceutical Market Access and Drug Safety Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.
Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use.
Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions.
Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.
Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug.
States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.
Requires the Secretary to educate consumers regarding prescription drug importation.
Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA.
Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.
Cosponsors 36
Members who signed on, in the order they did. Signatures ran from Mar 4, 2009 to Sep 16, 2010; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-MO | Jo Ann Emerson | Original | Mar 4, 2009 |
| D-TN | Bart Gordon | Mar 19, 2009 | |
| D-NH | Carol Shea-Porter | Mar 19, 2009 | |
| D-MD | Chris Van Hollen | Mar 19, 2009 | |
| D-PA | Christopher P. Carney | Mar 19, 2009 | |
| D-MI | Dale E. Kildee | Mar 19, 2009 | |
| R-IN | Dan Burton | Mar 19, 2009 | |
| D-MS | Gene Taylor | Mar 19, 2009 | |
| D-OH | Marcy Kaptur | Mar 19, 2009 | |
| R-ID | Michael K. Simpson | Mar 19, 2009 | |
| R-VA | Frank R. Wolf | Apr 2, 2009 | |
| D-IL | Janice D. Schakowsky | Apr 2, 2009 | |
| R-WA | Doc Hastings | Apr 27, 2009 | |
| R-MI | Peter Hoekstra | Apr 27, 2009 | |
| R-WI | Thomas E. Petri | Apr 27, 2009 |
Withdrew 1 Rodney Alexander R-LA Oct 27, 2009
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 4, 2009 |
| Health Subcommittee | Referred Mar 5, 2009 |
Actions 3
Everything that happened, newest first.
- Mar 5, 2009Referred to the Subcommittee on Health.
- Mar 4, 2009Introduced in House
- Mar 4, 2009Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
About this bill 1
Products that name it in their title: its number, its law number or one of its short titles.
| Product | Title | Kind | Published |
|---|---|---|---|
| RS22660 | Prescription Drug Importation: How S. 1232 (S. 525/H.R. 1298) Would Change Current Law Archived | Report | Jun 16, 2009 |
Related bills 4
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 525 | Pharmaceutical Market Access and Drug Safety Act of 2009 | Identical bill | Mar 5, 2009 |
| S 1232 | Pharmaceutical Market Access and Drug Safety Act of 2009 | Identical bill | Jun 11, 2009 |
| S 1808 | Control Spending Now Act | Related bill | Oct 20, 2009 |
| S 3415 | Fair Pricing for Prescription Drugs Act | Related bill | May 25, 2010 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
- Short Titles as Introduced
- Pharmaceutical Market Access and Drug Safety Act of 2009
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Administrative remedies
- Asia
- Australia
- Business records
- Canada
- Civil actions and liability
- Consumer affairs
- Consumer credit
- Contracts and agency
- Department of Health and Human Services
- Europe
- European Union
- Evidence and witnesses
- Federal preemption
- Federal Trade Commission (FTC)
- Food and Drug Administration (FDA)
- Fraud offenses and financial crimes
- Government studies and investigations
- Health
- Health information and medical records
- Intellectual property
- Intergovernmental relations
- Internet and video services
- Internet, web applications, social media
- Japan
- Marketing and advertising
- Medical education
- Medical tests and diagnostic methods
- New Zealand
- Oceania
- Prescription drugs
- Product safety and quality
- Retail and wholesale trades
- Switzerland
- Trade restrictions
- User charges and fees
Text 1
Each version as it was printed, newest first.
- Mar 4, 2009Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.